Leukotriene enhanced allergic lung inflammation through induction of chemokine production

Clinical and Experimental Medicine

Volumn 15, Issue 3, 2015, Pages 233-244

  Shin, Kihyuk ^a   Hwang, Jung Joo ^a,b   Kwon, Bo In ^a   Kheradmand, Farrah ^c,d   Corry, David B ^c,d   Lee, Seung Hyo ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Eulji University   (South Korea)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Center for Translational Injury Research   (United States)

Author keywords

Chemokines; Interleukin 13 (IL 13); Leukotrienes (LTs); Lung inflammation

Indexed keywords

ALLERGEN; CHEMOKINE; GAMMA INTERFERON; GLYCOPROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; LEUKOTRIENE; LEUKOTRIENE B4; MONOCYTE CHEMOTACTIC PROTEIN 3; THYMUS AND ACTIVATION REGULATED CHEMOKINE; PEPTIDE HYDROLASE; RECOMBINANT PROTEIN;

AIRWAY; ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; CELL COUNT; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME METABOLISM; GOBLET CELL; INFLAMMATORY CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; TH2 CELL; WILD TYPE; ANIMAL; ASPERGILLUS; ASTHMA; DISEASE MODEL; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

ASPERGILLUS; MUS;

ALLERGENS; ANIMALS; ASPERGILLUS; ASTHMA; CHEMOKINES; DISEASE MODELS, ANIMAL; INTERLEUKIN-13; LEUKOTRIENES; MICE; PEPTIDE HYDROLASES; RECOMBINANT PROTEINS;

EID: 84938421136     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-014-0292-7     Document Type: Article

References (44)

1. D’Amato G, Cecchi L, D’Amato M, Liccardi G (2010) Urban air pollution and climate change as environmental risk factors of respiratory allergy: an update. J Investig Allergol Clin Immunol 20(2):95–102 (quiz following 102)
2. Cohn L, Elias JA, Chupp GL (2004) Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 22:789–815
3. Corry DB, Kheradmand F (2002) Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma. Am J Respir Med 1(3):185–193
4. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, Senior RM, Elias JA (2001) Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 194(6):809–821
5. Baram D, Vaday GG, Salamon P, Drucker I, Hershkoviz R, Mekori YA (2001) Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J Immunol 167(7):4008–4016
6. Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z, Elias JA, Sheppard D, Erle DJ (2002) Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 8(8):885–889
7. Mattes J, Yang M, Siqueira A, Clark K, MacKenzie J, McKenzie AN, Webb DC, Matthaei KI, Foster PS (2001) IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung. J Immunol 167(3):1683–1692
8. Walter DM, McIntire JJ, Berry G, McKenzie AN, Donaldson DD, DeKruyff RH, Umetsu DT (2001) Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 167(8):4668–4675
9. Elias JA, Lee CG, Zheng T, Shim Y, Zhu Z (2003) Interleukin-13 and leukotrienes: an intersection of pathogenetic schema. Am J Respir Cell Mol Biol 28(4):401–404
10. Leff AR (2000) Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways. Am J Respir Crit Care Med 161(2 Pt 2):S125–S132
11. Haeggstrom JZ, Funk CD (2011) Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem Rev 111(10):5866–5898. doi:10.1021/cr200246d
12. Feussner I, Wasternack C (2002) The lipoxygenase pathway. Annu Rev Plant Biol 53:275–297. doi:10.1146/annurev.arplant.53.100301.135248
13. Tug T, Godekmerdan A, Sari N, Karatas F, Erdem ES (2007) Effects of supportive treatment such as antioxidant or leukotriene receptor antagonist drugs on inflammatory and respiratory parameters in asthma patients. Clin Pharmacol Ther 81(3):371–376. doi:10.1038/sj.clpt.6100091
14. Singh RK, Gupta S, Dastidar S, Ray A (2010) Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology 85(6):336–349. doi:10.1159/000312669
15. Thivierge M, Stankova J, Rola-Pleszczynski M (2001) IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol 167(5):2855–2860
16. Vargaftig BB, Singer M (2003) Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. Am J Respir Cell Mol Biol 28(4):410–419
17. Yoshie O (2000) Role of chemokines in trafficking of lymphocytes and dendritic cells. Int J Hematol 72(4):399–407
18. Kunkel EJ, Butcher EC (2002) Chemokines and the tissue-specific migration of lymphocytes. Immunity 16(1):1–4
19. Matsukawa A, Hogaboam CM, Lukacs NW, Kunkel SL (2000) Chemokines and innate immunity. Rev Immunogenet 2(3):339–358
20. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M (2003) Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol 111(6):1185–1199 (quiz 1200)
21. D’Ambrosio D, Albanesi C, Lang R, Girolomoni G, Sinigaglia F, Laudanna C (2002) Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion. J Immunol 169(5):2303–2312
22. Johnston B, Butcher EC (2002) Chemokines in rapid leukocyte adhesion triggering and migration. Semin Immunol 14(2):83–92
23. Chen XS, Sheller JR, Johnson EN, Funk CD (1994) Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372(6502):179–182
24. Lee SH, Prince JE, Rais M, Kheradmand F, Shardonofsky F, Lu H, Beaudet AL, Smith CW, Soong L, Corry DB (2003) Differential requirement for CD18 in T-helper effector homing. Nat Med 9(10):1281–1286. doi:10.1038/nm932
25. Lee SH, Kiss A, Xu J, Qian Y, Bashoura L, Kheradmand F, Corry DB (2004) Airway glycoprotein secretion parallels production and predicts airway obstruction in pulmonary allergy. J Allergy Clin Immunol 113(1):72–78. doi:10.1016/j.jaci.2003.09.039
26. Corry DB, Rishi K, Kanellis J, Kiss A, Song LZ, Xu J, Feng L, Werb Z, Kheradmand F (2002) Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol 3(4):347–353
27. Corry DB, Grunig G, Hadeiba H, Kurup VP, Warnock ML, Sheppard D, Rennick DM, Locksley RM (1998) Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 4(5):344–355
28. Tager AM, Bromley SK, Medoff BD, Islam SA, Bercury SD, Friedrich EB, Carafone AD, Gerszten RE, Luster AD (2003) Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 4(10):982–990
29. Kheradmand F, Kiss A, Xu J, Lee SH, Kolattukudy PE, Corry DB (2002) A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol 169(10):5904–5911
30. Lamhamedi-Cherradi SE, Martin RE, Ito T, Kheradmand F, Corry DB, Liu YJ, Moyle M (2008) Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12. J Immunol 180(9):6000–6009
31. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Corry DB (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282(5397):2261–2263
32. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD (1998) Interleukin-13: central mediator of allergic asthma. Science 282(5397):2258–2261
33. Han B, Luo G, Shi ZZ, Barrios R, Atwood D, Liu W, Habib GM, Sifers RN, Corry DB, Lieberman MW (2002) Gamma-glutamyl leukotrienase, a novel endothelial membrane protein, is specifically responsible for leukotriene D(4) formation in vivo. Am J Pathol 161(2):481–490
34. Chavez J, Young HW, Corry DB, Lieberman MW (2006) Interactions between leukotriene C4 and interleukin 13 signaling pathways in a mouse model of airway disease. Arch Pathol Lab Med 130(4):440–446
35. Shim YM, Zhu Z, Zheng T, Lee CG, Homer RJ, Ma B, Elias JA (2006) Role of 5-lipoxygenase in IL-13-induced pulmonary inflammation and remodeling. J Immunol 177(3):1918–1924
36. Miyahara N, Takeda K, Miyahara S, Taube C, Joetham A, Koya T, Matsubara S, Dakhama A, Tager AM, Luster AD, Gelfand EW (2005) Leukotriene B4 receptor-1 is essential for allergen-mediated recruitment of CD8 + T cells and airway hyperresponsiveness. J Immunol 174(8):4979–4984
37. Chibana K, Ishii Y, Asakura T, Fukuda T (2003) Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin. J Immunol 170(8):4290–4295
38. Zhou X, Hu H, Balzar S, Trudeau JB, Wenzel SE (2012) MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-beta1 and IL-13 in human airway fibroblasts. J Immunol 188(12):6046–6054. doi:10.4049/jimmunol.1102760
39. Hashimoto K, Ichiyama T, Hasegawa M, Hasegawa S, Matsubara T, Furukawa S (2009) Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-kappaB pathways. Int Arch Allergy Immunol 149(3):275–282. doi:10.1159/000199724
40. Ichiyama T, Hasegawa M, Ueno Y, Makata H, Matsubara T, Furukawa S (2005) Cysteinyl leukotrienes induce monocyte chemoattractant protein 1 in human monocytes/macrophages. Clin Exp Allergy: J Br Soc Allergy Clin Immunol 35(9):1214–1219. doi:10.1111/j.1365-2222.2005.02323.x
41. Kuperman D, Schofield B, Wills-Karp M, Grusby MJ (1998) Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 187(6):939–948
42. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE (1999) The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17:701–738
43. Drazen JM, Israel E, O’Byrne PM (1999) Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340(3):197–206
44. Currie GP, Srivastava P, Dempsey OJ, Lee DK (2005) Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists. QJM 98(3):171–182